United Health Products (UEEC) Common Equity (2010 - 2026)

United Health Products (UEEC) has reported Common Equity for 17 consecutive years, with -$4.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 39.15% year-over-year to -$4.4 million in Q2 2026; TTM through Jun 2026 was -$4.4 million, a 39.15% decrease from a year earlier, with the FY2025 full-year figure at -$4.0 million, down 62.07% from the prior year.
• Common Equity was -$4.4 million for Q2 2026 at United Health Products, down from -$4.3 million in the prior quarter.
• Over five years, Common Equity peaked at -$1.7 million in Q4 2023 and troughed at -$4.4 million in Q2 2026.
• A 5-year average of -$2.6 million and a median of -$2.1 million in 2022 frame the typical range for Common Equity.
• Across the five-year window, Common Equity plunged 4981.31% in 2022 and grew 21.42% in 2023, its largest moves.
• Over 5 years, Common Equity stood at -$2.1 million in 2022, then gained by 16.98% to -$1.7 million in 2023, then slumped by 43.43% to -$2.5 million in 2024, then plunged by 62.07% to -$4.0 million in 2025, then retreated by 11.49% to -$4.4 million in 2026.
• The last three Common Equity figures came in at -$4.4 million (Q2 2026), -$4.3 million (Q1 2026), and -$4.0 million (Q4 2025), per Business Quant data.